Stanford to use Sequentify Kits for Hematological Malignancies NGS Sequencing
Sequentify announced Stanford will be using the company’s NGS targeted panels for acute myeloid leukemia (AML) somatic mutation detection.
Read MorePosted by Andy Lundin | Nov 8, 2023 | Leukemia, Sequencing Systems |
Sequentify announced Stanford will be using the company’s NGS targeted panels for acute myeloid leukemia (AML) somatic mutation detection.
Read MorePosted by Andy Lundin | Oct 24, 2023 | Cancer |
Researchers detected cancer earlier in individuals with Li-Fraumeni syndrome, an inherited condition with a high risk of developing cancer.
Read MorePosted by Andy Lundin | Oct 23, 2023 | Cancer, Molecular Diagnostics |
VolitionRx detailed a new liquid biopsy cancer-detection method at the annual congress of the European Society for Medical Oncology.
Read MorePosted by Andy Lundin | Sep 27, 2023 | Immunoassay |
Mission Bio’s Tapestri Single-cell MRD AML Multiomics Assay is designed to bring resolution to disease relapse in acute myeloid leukemia.
Read MorePosted by Andy Lundin | Sep 13, 2023 | Unknown Origin & Other Cancer Types |
The study’s impact is multifaceted, potentially influencing the development of non-invasive diagnostic tests and novel medicines.
Read More